|
Market Closed -
Nasdaq
23:00:00 14/10/2026 +03
|
5-day change | 1st Jan Change | ||
| 8.050 USD | -0.25% |
|
+1.26% | +3.21% |
| 10-05 | Biocryst Pharmaceuticals, Inc. Announces Formation of Scientific Advisory Board | CI |
| 10-05 | BioCryst Pharmaceuticals Forms Scientific Advisory Board as R&D Model Evolves | MT |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | -0.25% | +1.26% | -0.86% | -18.77% | +3.21% | +14.35% | +35.52% | -46.30% | +93.51% | 2.06B | |
| -2.01% | -7.86% | +1.94% | +28.23% | +70.10% | +54.60% | +70.97% | +3.48% | - | 70.44B | |
| +3.84% | -10.61% | -12.60% | -1.76% | +4.10% | +6.97% | +57.43% | +191.71% | +4,921.53% | 50.31B | |
| +3.35% | +1.60% | +10.20% | -0.54% | +8.85% | +10.58% | +40.01% | -18.60% | +223.25% | 47.51B | |
| +0.51% | +0.78% | +0.09% | +26.24% | +16.24% | +28.58% | +31.43% | +8.49% | +246.12% | 42.91B | |
| +2.70% | -3.18% | -5.03% | +5.20% | +142.96% | +296.96% | +547.01% | +595.61% | - | 40.39B | |
| +0.69% | -3.11% | +1.43% | +15.63% | +15.69% | +7.48% | +96.59% | -1.38% | +999.75% | 39.69B | |
| +0.06% | -1.43% | +0.90% | +2.68% | +4.30% | +10.47% | +43.27% | +1.48% | +150.60% | 30.59B | |
| -2.95% | -14.09% | +5.83% | +33.28% | +58.21% | +37.94% | +1.30% | -54.11% | - | 26.8B | |
| -0.39% | -7.39% | -8.34% | -1.57% | -6.87% | -13.33% | -14.40% | -64.45% | - | 22.36B | |
| +0.45% | -0.04% | +18.59% | +30.34% | +22.40% | +19.45% | +9.58% | -11.74% | +124.52% | 22.1B | |
| +1.03% | -7.07% | -24.43% | -10.40% | -43.81% | -40.35% | +294.95% | +239.20% | +592.56% | 21.14B | |
| +1.11% | +2.28% | +4.95% | +16.30% | +9.79% | +16.92% | +157.90% | +235.95% | +1,976.89% | 17.02B | |
| +2.15% | +1.28% | -7.03% | -4.80% | +180.86% | +152.40% | +365.04% | +1,842.82% | +746.76% | 15B | |
| -0.76% | +2.26% | +10.13% | +12.03% | +24.78% | +26.11% | +56.82% | -28.60% | +88.55% | 15.25B | |
| +1.70% | +0.42% | -13.86% | -14.41% | - | - | - | - | - | 14.66B | |
| +2.49% | +4.56% | +8.68% | +8.83% | +39.15% | +58.66% | +185.53% | +184.34% | +412.09% | 14.75B | |
| +1.00% | -0.97% | +8.53% | +31.45% | +51.39% | +76.98% | +58.10% | -25.03% | +273.25% | 14.27B | |
| -2.84% | -8.54% | -6.02% | -13.25% | +11.47% | -11.64% | +428.02% | - | - | 13.7B | |
| -2.51% | -12.59% | -13.79% | -1.11% | -13.49% | -34.02% | +800.60% | +182.28% | +45.06% | 12.41B | |
| Average | +0.47% | -3.63% | -1.03% | +7.18% | +31.54% | +37.85% | +171.88% | +179.73% | +778.18% | 26.67B | |
| Weighted average by Cap. | +0.67% | -4.47% | -0.63% | +10.77% | +35.34% | +44.76% | +140.77% | +140.72% | +1,116.65% |
- Stock Market
- Stocks
- BCRX Stock
- Sector BioCryst Pharmaceuticals, Inc.
Select your edition
All financial news and data tailored to specific country editions
